We have previously shown that high mRNA levels of S6K2 and/or 4EBP1 are associated with a poor outcome in breast cancer, independent of other clinicopathological factors, whereas this was less prominent for high S6K1 levels [8]. The gene discussed is RPS6KB1; the disease is breast cancer.